Transcat (NASDAQ:TRNS) CEO Acquires $230,366.50 in Stock

Transcat, Inc. (NASDAQ:TRNS) CEO Jaime Irick acquired 2,275 shares of the business’s stock in a transaction that occurred on Thursday, November 5th. The shares were purchased at an average price of $101.26 per share, with a total value of $230,366.50. Following the completion of the acquisition, the chief executive officer owned 2,275 shares of the company’s stock, valued at $230,366.50. This represents a ∞ increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Transcat Price Performance

TRNS opened at $101.51 on Monday. The stock has a fifty day moving average price of $86.94 and a 200 day moving average price of $82.43. The company has a current ratio of 2.57, a quick ratio of 2.19 and a debt-to-equity ratio of 0.38. Transcat, Inc. has a 1 year low of $50.23 and a 1 year high of $110.47. The stock has a market cap of $954.19 million, a price-to-earnings ratio of 211.48 and a beta of 0.61.

Transcat (NASDAQ:TRNS) last issued its earnings results on Tuesday, November 3rd. The scientific and technical instruments company reported $0.64 earnings per share for the quarter, topping the consensus estimate of $0.45 by $0.19. Transcat had a return on equity of 6.14% and a net margin of 1.26%. The company had revenue of $97.09 million for the quarter, compared to analyst estimates of $92.46 million. Analysts forecast that Transcat, Inc. will post 2.06 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Russell Investments Group Ltd. increased its holdings in shares of Transcat by 41.8% during the 3rd quarter. Russell Investments Group Ltd. now owns 24,929 shares of the scientific and technical instruments company’s stock worth $2,204,000 after purchasing an additional 7,348 shares during the period. R Squared Ltd bought a new stake in shares of Transcat in the third quarter valued at about $274,000. Riverbridge Partners LLC lifted its stake in shares of Transcat by 8.4% in the third quarter. Riverbridge Partners LLC now owns 219,452 shares of the scientific and technical instruments company’s stock valued at $19,404,000 after buying an additional 17,063 shares during the period. Summit Creek Advisors LLC lifted its stake in shares of Transcat by 23.8% in the third quarter. Summit Creek Advisors LLC now owns 58,135 shares of the scientific and technical instruments company’s stock valued at $5,140,000 after buying an additional 11,165 shares during the period. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of Transcat in the third quarter valued at about $221,000. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

TRNS has been the topic of several recent research reports. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Transcat in a research report on Tuesday, August 25th. Oppenheimer upgraded shares of Transcat from a “market perform” rating to an “outperform” rating and set a $115.00 target price for the company in a research note on Wednesday, November 4th. Northland Securities raised shares of Transcat from a “market perform” rating to an “outperform” rating and set a $95.00 target price for the company in a research report on Wednesday, October 21st. CJS Securities started coverage on shares of Transcat in a research note on Tuesday, October 27th. They set an “outperform” rating and a $115.00 price target on the stock. Finally, Zacks Research upgraded shares of Transcat from a “hold” rating to a “strong-buy” rating in a report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $108.33.

More Transcat News

Here are the key news stories impacting Transcat this week:

• Positive Sentiment: Zacks upgraded Transcat to Rank #1 (Strong Buy), citing improving earnings prospects, and included TRNS on its Strong Buy momentum-stock list. Zacks Strong Buy upgrade
• Positive Sentiment: Northland Securities raised its EPS forecasts across 2027–2031, including lifting its FY2027 estimate to $2.00 from $1.71 and its FY2031 estimate to $3.69 from $3.53. The revisions suggest stronger expected earnings growth. Northland estimate revisions
• Positive Sentiment: Oppenheimer raised its rating on Transcat to Outperform, adding to the favorable analyst sentiment. Oppenheimer rating upgrade
• Positive Sentiment: Recent coverage linked TRNS reaching a 52-week high to an earnings beat and improved outlook. The supplied background also reports quarterly EPS of $0.64 versus a $0.45 consensus estimate, with revenue above forecasts. Transcat 52-week high following earnings beat
• Neutral Sentiment: Northland maintained an Outperform rating but set a $95 price target, below the $101.32 share price cited in the background; this may temper the impact of its higher earnings forecasts. Northland rating and target

About Transcat

Transcat, Inc (NASDAQ: TRNS) provides calibration, compliance, and measurement services for organizations that rely on accurate test and measurement equipment. The company supports customers in regulated industries, including life sciences, aerospace and defense, energy, manufacturing, and other industrial markets.

Its service offerings include laboratory and onsite calibration, repair, validation, and asset-management services. Transcat calibrates a broad range of equipment used to measure temperature, pressure, electrical and electronic properties, radio frequency signals, dimensional characteristics, and other technical parameters.